| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/03/2013 | CN103183667A Electronic transmission material and preparation method and application thereof |
| 07/03/2013 | CN103183666A Cyclopiazonic acid compound, and preparation and application thereof |
| 07/03/2013 | CN103183665A Substance having tyrosine kinase inhibition activity, preparation method and application |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN101970418B Pyrazine derivative and its uses as protein kinase inhibitor |
| 07/02/2013 | US8476457 Indole, indazole and benzimidazole arylamides as P2X3 and P2X2/3 antagonists |
| 07/02/2013 | US8476454 IDO inhibitors and methods of use |
| 07/02/2013 | US8476434 Protein kinase modulators and method of use |
| 07/02/2013 | US8476286 Quinazoline derivatives which promote the release of parathyroid hormone |
| 07/02/2013 | US8476262 Cyanopyrroles |
| 07/02/2013 | US8475940 Anthracene derivative and light-emitting device |
| 07/02/2013 | CA2748249C Cyclic amine compounds |
| 07/02/2013 | CA2737694C Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 07/02/2013 | CA2731897C Diazepine and diazocane compounds as mc4 agonists |
| 07/02/2013 | CA2657469C Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 06/27/2013 | WO2013096194A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/27/2013 | WO2013095275A1 Novel hepatitis c virus inhibitors |
| 06/27/2013 | WO2013094999A2 Organic compound, and organic electroluminescent device using same |
| 06/27/2013 | WO2013092854A1 Pyrimidine-2,4-diamine derivatives as kinase inhibitors |
| 06/27/2013 | WO2013092790A1 Radiofluorination method |
| 06/27/2013 | WO2013092711A1 Trpm8 antagonists |
| 06/27/2013 | WO2013092616A1 New aziridine compounds, pharmaceutical compositions and their use as acetyl-coa carboxylase inhibitors |
| 06/27/2013 | WO2013092522A1 Novel insecticidal aromatic amides |
| 06/27/2013 | WO2013092244A1 Herbicidal triazines |
| 06/27/2013 | WO2013091539A1 Pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medicinal uses thereof |
| 06/27/2013 | WO2013091507A1 Heterocycle amido alkyloxy substituted quinazoline derivative and use thereof |
| 06/27/2013 | WO2013091474A1 Carboxylic acid type water-soluble sulfur dye |
| 06/27/2013 | US20130165491 Therapeutic agent for pain |
| 06/27/2013 | US20130165464 Heteroaryls and uses thereof |
| 06/27/2013 | US20130165452 Substituted Heteroaryls |
| 06/27/2013 | US20130165446 Benzo-or pyrido-imidazole derivative |
| 06/27/2013 | US20130165443 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists |
| 06/27/2013 | US20130165440 JAK1 Inhibitors |
| 06/27/2013 | US20130165431 Inhibitors of syk and jak protein kinases |
| 06/27/2013 | US20130165423 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists |
| 06/27/2013 | US20130165412 Cannabinoid receptor modulators |
| 06/27/2013 | US20130164259 1,4-substituted piperazine derivatives and methods of use thereof |
| 06/27/2013 | US20130164258 Antiviral Compounds Composed of Three Aligned Aryl Moieties to Treat Diseases such as Hepatitis C |
| 06/27/2013 | DE102012022880A1 Electronic device e.g. organic integrated circuits, organic field-effect transistors, organic thin-film transistors, organic light emitting transistors, comprises an organic layer comprising substituted heteroaryl compounds |
| 06/27/2013 | CA2857977A1 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
| 06/27/2013 | CA2856448A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/26/2013 | EP2607356A1 Triazole-substituted arylamide derivatives and their use as P2x3 and /or P2x2/3 purinergic receptor antagonists |
| 06/26/2013 | EP2606888A1 Trpm8 antagonists |
| 06/26/2013 | EP2606042A1 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor |
| 06/26/2013 | EP2606038A1 Compounds for the treatment of hepatitis c |
| 06/26/2013 | EP2606036A1 New compounds |
| 06/26/2013 | EP2606035A1 Proces for the synthesis of substituted urea compounds |
| 06/26/2013 | EP2606034A1 Pyrimidine derivatives as fak inhibitors |
| 06/26/2013 | EP2606032A2 Composition and methods for treating glioblastoma |
| 06/26/2013 | CN103180313A 有机电致发光装置 Organic electroluminescent device |
| 06/26/2013 | CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine |
| 06/26/2013 | CN103180310A Hetero-bicyclic derivatives as hcv inhibitors |
| 06/26/2013 | CN103180309A Antagonist for mutated androgen receptor |
| 06/26/2013 | CN103180302A 1,2-bis-(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane and intermediate thereof |
| 06/26/2013 | CN103180291A Alkoxyimino derivative and pest control agent |
| 06/26/2013 | CN103172627A Heterocyclic benzopyrimidine or quinoline compound and applications thereof |
| 06/26/2013 | CN103172620A Anti-viral compounds |
| 06/26/2013 | CN103172619A 4-(substituted benzyl)-1(2H)-2,3-phthalazinone derivatives, and preparation methods, medicinal compositions and uses thereof |
| 06/26/2013 | CN103172570A Fungicide n-6-membered fused (hetero) aryl-methylene-n-cycloalkyl carboxamide derivatives |
| 06/26/2013 | CN102196809B Agent for treatment of diabetic nephropathy |
| 06/26/2013 | CN101633656B Method for synthesizing candesartan cilexetil as candesartan medicament |
| 06/26/2013 | CN101426780B Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/25/2013 | US8471031 Process for the preparation of sterically hindered nitroxyl ethers |
| 06/25/2013 | US8471014 Process of making gyrase and topoisomerase IV inhibitors |
| 06/25/2013 | US8471005 Pyrrolotriazines as ALK and JAK2 inhibitors |
| 06/25/2013 | US8470866 Isoindolinone derivatives |
| 06/25/2013 | US8470857 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents |
| 06/25/2013 | US8470831 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 06/25/2013 | US8470829 Imidazolidine derivative and use thereof |
| 06/25/2013 | US8470827 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 06/25/2013 | US8470820 Nitrogen-containing heteroaryl derivatives |
| 06/25/2013 | US8470819 Benzimidazole and aza-benzimidazole carboxamides |
| 06/25/2013 | US8470814 Diazepinedione derivative |
| 06/25/2013 | CA2725425C Homocysteine synthase inhibitor |
| 06/25/2013 | CA2577446C 2-arylcarbamoyl-indoles as cytokine inhibitors |
| 06/25/2013 | CA2570264C 3-aminoindazoles |
| 06/20/2013 | WO2013090454A2 Novel glp-1 receptor modulators |
| 06/20/2013 | WO2013089212A1 Substituted triazine derivative and pharmaceutical composition containing same |
| 06/20/2013 | WO2013087932A1 Coupler with 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses |
| 06/20/2013 | WO2013087807A1 4-aryl imidazole derivatives as mglu5 positive allesteric modiulators |
| 06/20/2013 | WO2013087806A1 Piperazine derivatives and their use as positive allosteric modulators of mglu5 receptors |
| 06/20/2013 | WO2013087805A1 Piperazine derivatives and their use as positive allosteric modulators of mglu5 receptors |
| 06/20/2013 | WO2013087739A1 4-aryl imidazole derivatives as mglur5 positive allosteric modulators |
| 06/20/2013 | WO2013087738A1 Novel compounds |
| 06/20/2013 | WO2013087643A1 1,3,5 -triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof |
| 06/20/2013 | WO2013087577A1 N-(1,2,5-oxadiazol-3-yl), n-(1,3,4-oxadiazol-2-yl), n-(tetrazol-5-yl), and n-(triazol-5-yl) aryl carboxylic acid amides and use thereof as herbicides |
| 06/20/2013 | WO2013063458A3 Inhibiting g protein coupled receptor 6 kinase polypeptides |
| 06/20/2013 | WO2013062294A3 Improved preparation method for mitiglinide calcium |
| 06/20/2013 | WO2013056142A3 Meso-biliverdin compositions and methods |
| 06/20/2013 | US20130158259 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/20/2013 | US20130158258 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/20/2013 | US20130158084 Pharmaceutical Composition Comprising Losartin For Treating or Preventing Statin BasedGrug-Induced Muscle Toxicity |
| 06/20/2013 | US20130158057 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/20/2013 | US20130158042 Novel compounds |
| 06/20/2013 | US20130158041 Tyrosine Kinase Inhibitors |
| 06/20/2013 | US20130158038 Novel compounds |
| 06/20/2013 | US20130158032 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/20/2013 | US20130158030 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof |
| 06/20/2013 | US20130158021 Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| 06/20/2013 | US20130158019 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |